Functional and in Situ evidence for nitric oxide production driven by CD40-CD40L interactions in graft-versus-leukemia reactivity

Clinical Cancer Research

Volumn 6, Issue 5, 2000, Pages 1988-1996

  Müerköster, Susanne ^a   Laman, Jon D ^c   Rocha, Marian ^b   Umansky, Victor ^a   Schirrmacher, Volker ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b GLAXOSMITHKLINE   (United Kingdom)

^c ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD40 ANTIGEN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; SIALOADHESIN;

ADOPTIVE IMMUNOTHERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DENDRITIC CELL; GRAFT VERSUS LEUKEMIA EFFECT; LIVER METASTASIS; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE; TUMOR REGRESSION;

ANIMALS; ANTIBODIES, MONOCLONAL; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD40; APOPTOSIS; CD40 LIGAND; CELL COUNT; DOWN-REGULATION; GRAFT VS LEUKEMIA EFFECT; IMMUNOHISTOCHEMISTRY; IMMUNOTHERAPY, ADOPTIVE; LIVER; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED DBA; NEOPLASMS, EXPERIMENTAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; PROTEIN BINDING; RECEPTORS, IMMUNOLOGIC;

EID: 0343962991     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Schirrmacher, V., Beckhove, P., Krüger, A., Rocha, M., Umansky, V., Fichtner, K. P., Hull, W. E., Zangemeister-Wittke, U., Griesbach, A., Jurianz, K., and von Hoegen, P. Effective immune rejection of advanced metastasized cancer. Int. J. Oncol., 6: 505-521, 1995.
2. Schirrmacher, V., von Hoegen, P., Griesbach, A., Schild, H. J., and Zangemeister-Wittke, U. Specific eradication of micrometastases by transfer of tumour-immune T cells from major-histocompatibility-complex congenic mice. Cancer Immunol. Immunother., 32: 373-381, 1991.
3. Crocker, P. R., and Gordon, S. Properties and distribution of a lectin-like hemagglutinin differentially expressed by stromal tissue macrophages. J. Exp. Med., 164: 1862-1873, 1986.
4. Crocker, P. R., Kelm, S., Dubois, C., Martin, B., McWilliams, A. S., Shotton, D., Paulson, J. C., and Gordon, S. Purification and properties of sialoadhesin, a sialic acid-binding receptor of murine tissue macrophages. EMBO J., 10: 1661-1669, 1991.
5. van den Berg, T. K., Brevé, J. J. P., Damoiseaux, J. G. M. C., Döpp, E. A., Kelm, S., Crocker, P. R., Dijkstra, C. D., and Kraal, G. Sialoadhesin on macrophages: its identification as a lymphocyte adhesion molecule. J. Exp. Med., 176: 647-655, 1992.
6. Müerköster, S., Rocha, M., Crocker, P. R., Schirrmacher, V., and Umansky, V. Sialoadhesin-positive host macrophages play an essential role in graft-versus-leukemia (GvL) reactivity in mice. Blood, 93: 4375-4386, 1999.
7. Müerköster, S., Wachowski, O., Zerban-Michelfelder, H., Schirrmacher, V., Umansky, V., and Rocha, M. GvL reactivity involves cluster formation between superantigen-reactive donor T lymphocytes and host macrophages. Clin. Cancer Res., 4: 3095-3106, 1998.
8. Laman, J. D., Claassen, E., and Noelle, R. J. Functions of CD40 and its ligand, gp 39 (CD40L). Crit. Rev. Immunol., 16: 59-108, 1996.
9. Mackey, M. F., Barth, R. J., and Noelle, R. J. The role of CD40/CD154 interactions in the priming, differentiation, and effector function of helper and cytotoxic T cells. J. Leukocyte Biol., 63: 418-428, 1998.
10. Denfeld, R. W., Hollenbaugh, D., Fehrenbach, A., Weiss, J. M., von Leoprechting, A., Mai, B., Voith, U., Schopf, E., Aruffo, A., and Simon, J. C. CD40 is functionally expressed on human keratinocytes. Eur. J. Immunol. 26: 2329-2334, 1996.
11. Caux, C., Massacrier, C., Vanbervliet, B., Dubois, B., van Kooten C., Durand, I., and Banchereau, J. Activation of human dendritic cells through CD40 cross-linking. J. Exp. Med., 180: 1263-1272, 1994.
12. Peguet, N. J., Dalbiez, G. C., Rattis, F. M., Van Kooten, C., Banchereau, J., and Schmitt, D. Functional expression of CD40 antigen on human epidermal Langerhans cells. J. Immunol., 155: 4241-4247, 1995.
13. Clark, E. A., Lane, P. J. L. Regulation of human B cell activation and adhesion. Annu. Rev. Immunol., 9: 97-127, 1991.
14. Cella, M., Scheidegger, D., Palmer-Lehmann, K., Lane, P., Lanzavecchia, A., and Alber, G. Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulation capacity: T-T help via APC activation. J. Exp. Med., 184: 747-752, 1996.
15. Kennedy, M. K., Mohler, K. M., Shanebeck, K. D., Baum, P. R., Picha, K. S., Ottene-Evans, C. A., Janeway, C. A., and Grabstein, K. H. Induction of B cell costimulatory function by recombinant murine CD40 ligand. Eur. J. Immunol., 24: 116-123, 1994.
16. Ranheim, E. A., and Kipps, T. J. Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med., 177: 925-935, 1993.
17. Sallusto, F., and Lanzavecchia, A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulation by tumor necrosis factor α. J. Exp. Med., 179: 1109-1118, 1994.
18. Stout, R. D., Suttles, J., Xu, J., Grewal, I. S., and Flavell, R. A. Impaired T cell-mediated macrophage activation in CD40-deficient mice. J. Immunol., 156: 8-11, 1996.
19. Lu, L., Bonham, C. A., Chambers, F. G., Watkins, F. G., Hoffman, R. A., Simmons, R. L., and Thomson, A. W. Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells. J. Immunol., 157: 3577-3586, 1996.
20. Hollenbaugh, D., Mischel-Petty, N., Edwards, C. P., Simon, J. C., Denfield, R. W., Kiener, P. A., and Aruffo, A. Expression of CD40 by vascular endothelial cells. J. Exp. Med., 182: 33-40, 1995.
21. Marcinkiewicz, J., Grabowska, A., and Chain, B. Nitric oxide up-regulates the release of inflammatory mediators by mouse macrophages. Eur. J. Immunol., 25: 947-951, 1995.
22. Albina, J. E., and Reichner, J. S. Role of nitric oxide in mediation of macrophage cytotoxicity and apoptosis. Cancer Metastasis Rev., 17: 39-53, 1998.
23. Tian, L., Noelle, R. J., and Lawrence, D. A. Activated T cells enhance nitric oxide production by murine splenic macrophages through gp39 and LFA-1. Eur. J. Immunol., 25: 306-309, 1995.
24. Umansky, V., Bucur, M., Schirrmacher, V., and Rocha, M. Activated endothelial cells induce apoptosis in lymphoma cells: role of nitric oxide. Int. J. Oncol., 10: 465-471, 1997.
25. Coffman, R. L., and Weissman, I. L. A monoclonal antibody that recognizes B cells and B cell precursors in mice. J. Exp. Med., 153: 269-276, 1981.
26. Noelle, R. J., Roy, M., Shepherd, D. M., Stamenkovic, I., Ledbetter, J. A., and Aruffo, A. A 39-kDa protein on activated T helper cells binds CD40 and transduces the signal for cognate activation of B cells. Proc. Natl. Acad. Sci. USA, 89: 6550-6559, 1992.
27. Ridge, J. P., Di Rosa, F., and Matzinger, P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature (Lond.), 393: 474-478, 1998.
28. Schoenberger, S. P., Toes, R. E. M., van der Voort, E. I. H., Offringa, R., and Melief, C. J. M. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature (Lond.), 393: 480-483, 1998.
29. Bennett, S. R. M., Carbone, F. R., Karamalis, F., Flavell, R. A., Miller, J. F. A. P., and Heath, W. R. Help for cytotoxic-T-cell responses is mediated by CD40 signalling. Nature (Lond.), 393: 478-480, 1998.
30. Van den Eertwegh, A. J., Noelle, R. J., Roy, M., Shepperd, D. M., Aruffo, A., Ledbetter, J. A., Boersma, W. J., and Claassen, E. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines, and antibody production delineates sites of cognate T-B cell interactions. J. Exp. Med., 178: 1555-1563, 1993.
31. Heusel, J. W., Wesselschmidt, R. L., Shresta, S., Russell, J. H., and Ley, T. J. Cytotoxic lymphocytes require granzyme B for the rapid induction of DNA fragmentation and apoptosis in allogeneic target cells. Cell, 76: 977-985, 1994.
32. Schirrmacher, V., Beutner, U., Bucur, M., Umansky, V., Rocha, M., and von Hoegen, P. Loss of endogenous mouse mammary tumor virus superantigen increases tumor resistance. J. Immunol., 161: 563-572, 1998.
33. Matulonis, U., Dosiou, C., Freeman, G., Lamont, C., Mauch, P., Nadler, L. M., and Griffin, J. D. B7-1 is superior to B7-2 costimulation in the induction and maintenance of T cell-mediated antileukemia immunity. J. Immunol., 156: 1126-1131, 1996.
34. Mackey, F. M., Gunn, J. R., Maliszewski, C., Kikutani, H., Noelle, R. J., and Earth, R. J., Jr. Dendritic cells require maturation via CD40 to generate protective antitumor immunity. J. Immunol., 161: 2094-2098, 1998.
35. Marcinkiewicz, J., and Chain, B. M. Differential regulation of cytokine production by nitric oxide. Immunology, 80: 146-154, 1993.
36. Kolb, H., and Kolb-Bachofen, V. Nitric oxide in autoimmune disease: cytotoxic or regulatory mediator? Immunol. Today, 19: 556-561, 1998.